| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.5B | $11.5B | $11.5B | $10.7B | $9.5B | $2.8B | $2.4B | $2.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.5B | $0.8B | $0.6B | $0.5B | $0.3B | $0.2B | $0.2B |
| Net Income | $0.6B | $0.6B | $0.7B | $0.6B | $0.5B | $0.2B | $0.1B | $0.2B |
| EPS (Basic) | $15.39 | $13.96 | $17.07 | $14.44 | $13.50 | $6.15 | $3.62 | $4.96 |
| EPS (Diluted) | $15.39 | $13.96 | $17.07 | $14.44 | $13.50 | $6.15 | $3.61 | $4.94 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.7B | $12.1B | $11.2B | $10.9B | $10.6B | $8.2B | $7.0B | $6.4B |
| Current Assets | $3.5B | $3.2B | $2.9B | $2.7B | $2.8B | $2.4B | $1.8B | $1.7B |
| Cash & Equivalents | — | — | — | — | $0.6B | $0.5B | $0.1B | $0.2B |
| Total Liabilities | $7.7B | $7.5B | $7.1B | $7.4B | $7.8B | $6.3B | $5.4B | $4.9B |
| Current Liabilities | $3.0B | $3.0B | $3.0B | $2.9B | $2.4B | $2.2B | $1.9B | $1.8B |
| Stockholders' Equity | $5.1B | $4.7B | $4.1B | $3.5B | $2.8B | $1.9B | $1.6B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.4B | $1.0B | $0.8B | $0.8B | $1.1B | $0.9B | $0.9B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.2B | $-0.3B | $-2.0B | $-0.8B | $-0.6B | $-0.5B |
| Capital Expenditures | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B |
| Financing Cash Flow | $-0.7B | $0.4B | $-0.8B | $-0.7B | $1.3B | $0.1B | $-0.4B | $-0.9B |